Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan

被引:192
|
作者
Nishimura, JI
Kanakura, Y
Ware, RE
Shichishima, T
Nakakuma, H
Ninomiya, H
Decastro, CM
Hall, S
Kanamaru, A
Sullivan, KM
Mizoguchi, H
Omine, M
Kinoshita, T
Rosse, WF
机构
[1] Duke Univ, Med Ctr, Div Cellular Therapy, Durham, NC 27710 USA
[2] Govt Japan, Minist Hlth Labour & Welfare, Tokyo, Japan
[3] Tokyo Womens Med Coll, Dept Hematol, Tokyo 162, Japan
[4] Osaka Univ, Dept Immunoregulat, Microbial Dis Res Inst, Osaka, Japan
[5] Osaka Univ, Grad Sch med, Dept Hematol & Oncol, Osaka, Japan
[6] Kinki Univ, Sch Med, Dept Internal Med 3, Osaka 589, Japan
[7] Showa Univ, Fujigaoka Hosp, Div Hematol, Dept Med, Kanagawa, Japan
[8] Fukushima Med Univ, Dept Internal Med 1, Fukushima, Japan
[9] Wakayama Med Univ, Dept Hematol Oncol, Wakayama, Japan
[10] Univ Tsukuba, Div Hematol, Coll Med Technol, Ibaraki, Japan
关键词
D O I
10.1097/01.md.0000126763.68170.46
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine and directly compare the clinical course of white and Asian patients with paroxysmal nocturnal hemoglobin-uria (PNH), data were collected for epidemiologic analysis on 176 patients from Duke University and 209 patients from Japan. White patients were younger with significantly more classical symptoms of PNH including thrombosis, hemoglobinuria, and infection, while Asian patients were older with more marrow aplasia. The mean fraction of CD59-negative polymorphonuclear cells (PMN) at initial analysis was higher among Duke patients than Japanese patients. In both cohorts, however, a larger PNH clone was associated with classical PNH symptoms, while a smaller PNH clone was associated with marrow aplasia. Thrombosis was significantly more prevalent in white patients than Asian patients, and was associated with a significantly higher proportion of CD59-negative PMN. For individual patients, CD59-negative populations varied considerably over time, but a decreasing PNH clone portended hematopoietic failure. Survival analysis revealed a similar death rate in each group, although causes of death were different and significantly more Duke patients died from thrombosis. Japanese patients had a longer mean survival time (32.1 yr vs. 19.4 yr), although Kaplan-Meier survival curves were not significantly different. Poor survival in both groups was associated with age over 50 years, severe leukopenia/neutropenia at diagnosis, and severe infection as a complication; additionally, thrombosis at diagnosis or follow-up for Duke patients and renal failure for Japanese patients were poor prognostic factors. These data identify important differences between white and Asian patients with PNH. Identification of prognostic factors will help the design of prospective clinical trials for PNH.
引用
收藏
页码:193 / 207
页数:15
相关论文
共 50 条
  • [31] Differential utility of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria (PNH) in blood and marrow
    Olteanu, H
    Karandikar, NJ
    McKenna, RW
    Xu, Y
    MODERN PATHOLOGY, 2006, 19 : 240A - 241A
  • [32] A simple flow cytometric assay for routine paroxysmal nocturnal hemoglobinuria testing based on immature reticulocytes and granulocytes
    Tsagarakis, Nikolaos J.
    Paterakis, George
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (04) : 259 - 263
  • [33] A NOVEL DUAL-REAGENT SINGLE TUBE FLOW CYTOMETRIC ASSAY TO SCREEN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Bommannan, K.
    Sachdeva, M. U. S.
    Ahluwalia, J.
    Bose, P.
    Varma, N.
    HAEMATOLOGICA, 2017, 102 : 405 - 406
  • [34] Clinical Characteristics and Outcomes in Complement-Inhibitor-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria in the United States: A Retrospective Claims Database Analysis
    Shammo, Jamile
    Noshad, Sina
    Bilano, Ver
    Geevarghese, Lincy
    Fermont, Jilles
    Yen, Glorian
    Paulose, Jincy
    Boyd, Marley
    Rau, Reina
    Gutierrez, Cynthia
    Sorg, Rachael
    Chanpura, Mohin
    Lee, Soyon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S398 - S399
  • [35] Disease Management and Outcomes in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Analysis of Observational Data from the United States
    Shammo, Jamile
    Vijapur, Sushupta M.
    Snellman, Josefin
    Fermont, Jilles M.
    BLOOD, 2023, 142
  • [36] The use of flow cytometry in diagnosis of paroxysmal nocturnal hemoglobinuria
    Olteanu, Horatiu
    Xu, Yin
    LABMEDICINE, 2006, 37 (08): : 498 - 502
  • [37] TRANSIENT PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DURING COURSE OF APLASTIC ANEMIA
    KRUATRAC.M
    NANAKORN, S
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1974, 57 (08): : 427 - 432
  • [38] Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria
    Richards, SJ
    Rawstron, AC
    Hillmen, P
    CYTOMETRY, 2000, 42 (04): : 223 - 233
  • [39] Paroxysmal Nocturnal Hemoglobinuria: Grasping the Flow of Diagnostic Dilemmas
    Phuong-Lan Nguyen
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S88 - S88
  • [40] CLINICAL EXPERIENCE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE DONOSTIA HOSPITAL
    Zubicaray Salegui, J.
    Lopez Oreja, I
    Urquia Plazaola, A.
    Romero Fernandez, P.
    Ramiirez, M. A.
    HAEMATOLOGICA, 2015, 100 : 125 - 125